Literature DB >> 34541181

An ex vivo Perifusion Method for Quantitative Determination of Neuropeptide Release from Mouse Hypothalamic Explants.

Ophélia Le Thuc1,2,3, Jacques Noël1, Carole Rovère1.   

Abstract

The hypothalamus is a primary brain area which, in mammals, regulates several physiological functions that are all related to maintaining general homeostasis, by linking the central nervous system (CNS) and the periphery. The hypothalamus itself can be considered an endocrine brain region of some sort as it hosts in its different nuclei several kinds of neuropeptide-producing and -secreting neurons. These neuropeptides have specific roles and participate in the regulation of homeostasis in general, which includes the regulation of energy metabolism, feeding behavior, water intake and body core temperature for example. As previously mentioned, in order to exert their effects, these peptides have to be produced but also, and mostly, to be secreted. In this context, it is of great importance to be able to assess how certain conditions, diseases, or treatments can actually influence the secretion of neuropeptides, thus the function of the different neuropeptidergic circuits. One method to assess this is the perifusion of hypothalamic explants followed by quantification of peptides within the collected fractions. Here, we explain step-by-step how to collect fractions during ex vivo perifusion of hypothalamic explants in which one can determine quantitatively neuropeptide/neurohormone release from these viable isolated tissues. Hypothalami perifusion has two great advantages over other existing assays: (1) it allows pharmacological manipulation to dissect out signaling mechanisms underlying release of different neuropeptides/neurohormones in the hypothalamic explants and, (2) it allows simultaneous experiments with different conditions on multiple hypothalami preparations, (3) it is, to our knowledge, the only method that permits the study of neuropeptide secretion in basal conditions and under repeated stimulations with the same hypothalami explants.
Copyright © 2017 The Authors; exclusive licensee Bio-protocol LLC.

Entities:  

Keywords:  Endocrinology; Hypothalamic explants; Hypothalamus; Neuroendocrinology; Neuropeptide; Peptide; Perifusion; Release; Secretion

Year:  2017        PMID: 34541181      PMCID: PMC8413597          DOI: 10.21769/BioProtoc.2521

Source DB:  PubMed          Journal:  Bio Protoc        ISSN: 2331-8325


  4 in total

1.  Obestatin partially affects ghrelin stimulation of food intake and growth hormone secretion in rodents.

Authors:  Philippe Zizzari; Romaine Longchamps; Jacques Epelbaum; Marie Thérèse Bluet-Pajot
Journal:  Endocrinology       Date:  2007-01-04       Impact factor: 4.736

2.  Central CCL2 signaling onto MCH neurons mediates metabolic and behavioral adaptation to inflammation.

Authors:  Ophélia Le Thuc; Céline Cansell; Miled Bourourou; Raphaël Gp Denis; Katharina Stobbe; Nadège Devaux; Alice Guyon; Julie Cazareth; Catherine Heurteaux; William Rostène; Serge Luquet; Nicolas Blondeau; Jean-Louis Nahon; Carole Rovère
Journal:  EMBO Rep       Date:  2016-10-12       Impact factor: 8.807

3.  The chemokine SDF-1/CXCL12 modulates the firing pattern of vasopressin neurons and counteracts induced vasopressin release through CXCR4.

Authors:  Céline Callewaere; Ghazal Banisadr; Michel G Desarménien; Patricia Mechighel; Patrick Kitabgi; William H Rostène; Stéphane Mélik Parsadaniantz
Journal:  Proc Natl Acad Sci U S A       Date:  2006-05-15       Impact factor: 11.205

4.  In vivo and in vitro effects of ghrelin/motilin-related peptide on growth hormone secretion in the rat.

Authors:  V Tolle; P Zizzari; C Tomasetto; M C Rio; J Epelbaum; M T Bluet-Pajot
Journal:  Neuroendocrinology       Date:  2001-01       Impact factor: 4.914

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.